Psyched: St. Vincent OKs Psychedelics Program, Delic To Go Public, Field Trip Drug Update

Saint Vincent Okays Psychedelic Initiative

The Caribbean country of Saint Vincent and the Grenadines has approved an initiative to incentivize psychedelic research and wellness. 

The small English-speaking island nation, located about 100 miles north of Venezuela’s coast, has passed a measure that will allow for the “cultivation, research, processing, and prescription of psychedelic plant-based compounds including psilocybin, ibogaine, peyote, ketamine, dimethyltryptamine, ayahuasca and sassafras."

Much like Jamaica, Saint Vincent could become a hub for psychedelic research and psychedelic-assisted therapy clinics, leading to a possible trend of psychedelic retreats in the Caribbean region.

The initiative spun off a willingness to explore the possibilities offered by the country’s vast flora, which includes naturally-occurring psychedelic plants and fungi.

The country has granted three licenses so far to SVG Biomed, Mera Life Sciences and Ajori Health & Wellness. The psychedelic therapy program will be available to people from all nationalities and clinics will be regulated similarly to those in Canada and the United States, said a spokesperson for the SVG Bureau of Standards.

Delic Corp. To Go Public On The CSE

E-commerce and events company Delic Corp., which is focused on the psychedelics industry, announced last week it would be going public on the ‎Canadian Securities Exchange via a reverse takeover (RTO) of Molystar Resources Inc.

Delic was formed in 2019 as an umbrella media platform. It currently includes three subsidiary companies: an e-commerce lifestyle brand named The …

Full story available on Benzinga.com

More Psyched: St. Vincent OKs Psychedelics Program, Delic To Go Public, Field Trip Drug Update